What is the Chronic Kidney Disease (CKD) stage for a patient with an estimated Glomerular Filtration Rate (EGFR) of 69?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CKD Stage Classification for eGFR 69 mL/min/1.73 m²

An eGFR of 69 mL/min/1.73 m² corresponds to CKD Stage 2 (mildly decreased kidney function), but ONLY if there is evidence of kidney damage present for at least 3 months. 1, 2

Critical Diagnostic Requirement

  • Stage 2 CKD requires BOTH eGFR 60-89 mL/min/1.73 m² AND evidence of kidney damage - the eGFR alone is insufficient for diagnosis 1, 3
  • You must measure urinary albumin-to-creatinine ratio (UACR) immediately on a random spot urine sample to confirm kidney damage 1, 3
  • If UACR is <30 mg/g with no other markers of kidney damage (hematuria, structural abnormalities on imaging, or pathologic findings), this patient does NOT have CKD despite the eGFR of 69 3

Confirming Chronicity

  • Proof of chronicity requires abnormalities persisting for at least 3 months, which can be established by reviewing past eGFR measurements, past albuminuria measurements, imaging findings showing reduced kidney size or cortical thinning, or repeat measurements within and beyond the 3-month point 1
  • Do not assume chronicity based on a single abnormal eGFR, as this could represent acute kidney injury or acute kidney disease 1

If CKD Stage 2 is Confirmed

  • The patient has mildly decreased kidney function (eGFR 60-89 mL/min/1.73 m²) with evidence of kidney damage 2, 3
  • Target blood pressure <130/80 mmHg, initiating antihypertensive therapy if BP ≥130/80 mmHg 3
  • If UACR ≥30 mg/g and hypertension is present, initiate ACE inhibitor or ARB therapy 3
  • Monitor eGFR and UACR at least annually, or every 6-12 months depending on albuminuria severity 3

Common Pitfall to Avoid

  • The most critical error is diagnosing CKD based on eGFR alone - Stage 2 CKD absolutely requires documented kidney damage in addition to the mildly decreased eGFR 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chronic Kidney Disease Staging and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of CKD Stage 2

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the diagnostic criteria for Chronic Kidney Disease (CKD) according to the recent Kidney Disease: Improving Global Outcomes (KDIGO) guidelines?
What does a low eGFR indicate and how is it managed?
What does an estimated Glomerular Filtration Rate (eGFR) of 60 indicate in the context of Chronic Kidney Disease (CKD)?
What does an estimated Glomerular Filtration Rate (eGFR) of 6 indicate in the context of Chronic Kidney Disease (CKD)?
What is the recommended approach for managing pain in a patient with impaired renal function (eGFR <40)?
What is the mechanism of hydrochlorothiazide (HCTZ) in reducing the recurrence of calcium oxalate stones in patients with idiopathic hypercalciuria?
What is the recommended treatment for a patient presenting with shingles, considering their age, medical history, and current health status?
What is the recommended maintenance dose of digoxin (Digitalis) for a patient with atrial fibrillation, heart failure, and severe renal impairment (creatinine clearance of 19)?
What is the recommended treatment plan for a patient with early Degenerative Joint Disease (DJD) and a small left knee joint effusion?
What is the recommended regimen for elemental iron supplementation in patients at risk of iron deficiency anemia, particularly pregnant women, individuals with a history of gastrointestinal bleeding, or those with chronic kidney disease?
Can a patient with chronic obstructive pulmonary disease (COPD) or asthma use Trelegy (fluticasone furoate, umeclidinium, and vilanterol) with Advair (fluticasone and salmeterol)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.